If you care for children, an elderly individual or someone with a health condition, be prepared for summer weather and stay safe when temperatures...
Henry Ford STRIVE Study
The earlier that cancers can be found, the higher the chance of successful treatment. Mammograms detect many early breast cancers and save many lives. However additional tools are still needed in order to detect more cancers early. This study will look at whether a blood test can enhance the detection of cancer.
The purpose of the STRIVE Study is to develop and evaluate a blood test for detecting cancer early. This test, being developed by GRAIL, Inc., will use advanced technology to detect genetic material released into the blood by tumors.
Who can participate?
The study is currently open to women who are undergoing screening mammography at participating Henry Ford Health System locations.
What does participation involve?
- Read and sign a consent form that fully explains the study
- Complete an electronic questionnaire at a time and place most convenient for you
- Provide a blood sample around the time of your mammogram, drawn by a Henry Ford team member in the same clinic
Participation takes about 30 minutes on average. In appreciation for your time, you will receive a $25 gift card.
Follow-up regarding your health status is extremely important to the success of the study. The Henry Ford STRIVE research team will be monitoring electronic medical records for any new cancer diagnoses over the next 5 years. If you receive a cancer diagnosis or cancer care outside of Henry Ford Health System, we kindly ask that you contact the study team at 1-833-3-STRIVE (1-833-378-7483) or STRIVE@hfhs.org.
You will not receive any personal test results because this is a research study and the test is still under development.
How do I get started?
Visit JoinSTRIVE.com or contact our STRIVE Study Coordinators at 1-833-3-STRIVE (1-833-378-7483) or STRIVE@hfhs.org for more information.